We showed that blastoid-HGBL cases have distinctive immunophenotypic, molecular, and cytogenetic features, including more frequent expression of brighter CD45, CD20, CD38, BCL6, and MYC overexpression and less frequent bright CD10 and TdT expression. This evidence concerns the gene MS4A1 and high grade B-cell lymphoma.